TP53 and cancer: Our results are compatible with those of the previous study by Masciari et al. (9), who analyzed by 18F-FDG-PET/CT a group of 15 TP53 mutation carriers (or obligate carriers) with no diagnosis of cancer within 5 years prior to recruitment.